Contact Lens Spectrum

April 2006

Document #125




(p. 22) Discovering Dry Eye: Allergies and Dry Eye in Contact Lens Wearers, By Kelly K. Nichols, OD, MPH, PhD


  1. Hayes VY, Schnider CM, Veys J. An evaluation of 1-day disposable contact lens wear in a population of allergy sufferers. Cont Lens Anterior Eye. 2003 Jun;26(2):85-93.


  1. Lemp MA. Contact lenses and associated anterior segment disorders: dry eye, blepharitis, and allergy. Ophthalmol Clin North Am. 2003 Sep;16(3):463-9.




(p. 34) Fitting Scleral Lenses, By Mitchell M. Loftin, OD


1.                    Wollensak G. Otto Himmler: First Manufacturer of Lathe Cut Corneo-Scleral Lenses. [Comment]. [Biography. Comment. Historical Article. Letter to Editor]  Survey of Ophthalmology. 49(3): 374 – 375, 2004 May-June.

2.                    Romero-Rangel T. et al. Gas-permeable Scleral Contact Lens Therapy in Ocular Surface Disease. American Journal of Ophthalmology 130(1): 25-32, 2000 July. 

3.                    Romero-Rangel T. et al.  IBID.

4.                    Schein OD, Rosenthal P, Ducharme C. A Gas-Permeable Scleral Contact Lens for Visual Rehabilitation. American Journal of Ophthalmology 109: 318-322, 1900 March.

5.                    Romero-Rangel T. et al.  IBID.

6.                    Rosenthal P, Cotter J, Baum J. Treatment of Persistent Corneal Epithelial Defect with Extended Wear of a Fluid-Ventilated Gas-permeable Scleral Contact Lens. American Journal of Ophthalmology 130 (1): 33-41, 2000 July.

7.                    Rosenthal P, et al. IBID.

8.                    Sindt C. Notes taken at Heart of America Contact lens seminar . Corneal-Scleral GP lenses – The Next generation. February 13,2006.



(p. 40) Chemical Properties of Contact Lens Rewetters, By Loretta B. Szczotka-Flynn, OD, MS, FAAO


1.                  Global Industry Analysts, Inc. Contact Lens and Solutions. A Global Strategic Business Report. February 2004. San Jose, CA

2.                  Doughty MJ, Fonn D, Richter D, Simpson T, Caffery B, Gordon K. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci. Aug 1997:74(8);624-31.

3.                  Guillon M, Styles E, Guillon J-P,Maissa C. Preocular tear film characteristics of nonwearers and soft contact lens wearers. Optom Vis Sci. May 1997:74(5);273-79.

4.                  Hom M. Multi-purpose solutions and corneal health.  Rev of Contact Lenses. July 2003:24-27.

5.                  Tonge S, Jones L, Goodall S, Tighe B.  The ex vivo wettability of soft contact lenses.  Curr Eye Res.  2001;23(1):51-59.

6.                  Jones L & Christie C. Contact lens care. Part 9—rigid lens care systems: an overview. Optician.  Dec. 7, 2001;222(5830):22-27.

7.                  Lenton LM, Albietz JM.  Effect of carmellose-based artificial tears on the ocular surface in eyes after laser in situ keratomileusis. J Refract Surg. Mar-Apr 1999;15(Suppl):S227-S231.

8.                  Grene RB, Lankston P, Mordaunt J, Harrold M, Gwon A, Jones R. Unpreserved carboxymethylcellulose artificial tears evaluated in patients with keratoconjunctivitis sicca.  Cornea.  1992 Jul;11(4):294-301.

9.                  Vehige JG, Simmons PA, Anger C, Graham R, Tran L, Brady N.  Cytoprotective properties of carboxymethyl cellulose (CMC) when used prior to wearing contact lenses treated with cationic disinfecting agents [abstract].  Eye Contact Lens.  2003 Jul;29(3):177-80.

10.              Toda I, Shinozaki N, Tsubota K.  Hyroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjogren’s syndrome. Cornea.  1996;15(2):120-128. 

11.              Dudinski O, Finnin BC, Reed BL.  Acceptability of thickened eye drops to human subjects.  Curr Ther Res.  Feb 1983;33(2):322-337.

12.              Otto S, Roth HW.  Efficacy and tolerability of a polyvidon formulation in treatment of the dry eye syndrome [in German, English abstract].  Klin Monatsbl Augenheilkd.  1996;209:362-327.

13.              Bach FC, Adam JB, McWhirter HC, Johnson JE.  Ocular retention of artificial tear solution.  Ann Ophthalmol.  Feb 1972:4;116-119.

14.              Simmons PA, Donshik PC, Kelly WF, Vehige JG.  Conditioning of hydrogel lenses by a multipurpose solution containing an ocular lubricant. CLAO J.  2001 Oct; 27(4):192-194.

15.              Hu Z, Derrick J, inventors.  Bausch & Lomb Inc., assignee.  Ophthalmic compositions including glycerin and propylene glycol.  U.S. patent 5,800,807. September 1, 1998.

16.              Goa KL, Benfield P. Hyaluronic acid: a review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing. Drugs.  1994;47(3):536-566.

17.              Hamano T, Horimoto K, Lee M, Komemushi S.  Sodium hyaluronate eyedrops enhance tear film stability. Jpn J Ophthalmol.  1996;40:62-65.

18.              Mengher LS, Pandher KS, Bron AJ, Davey CC.  Effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes. Br J Ophthalmol.  1986;70:442-447.

19.              Canavan K & Kabat AG.  Practical tips for managing dry eye in contact lens patients. Clin Ref Optometry.  2003;1/14(6/7):198-202.

20.              Noecker, R.  Effects of common ophthalmic preservatives on ocular health.  Adv Ther. Sept/Oct 2001;18(5):205-215.

21.             Tripathi BJ, Tripathi RC, Kolli SP. Cytotoxicity of ophthalmic preservatives on human corneal epithelium.  Lens Eye Toxic Res.  1992; 9(3&4):361-375.

22.              Paugh JR, Brennan NA, Efron N.  Ocular response to hydrogen peroxide. Am J Optom Physiol Opt. 1988;65(2):91-98.

23.              Way WA, Matsumoto S, Apel LJ, Wiese A, Tarlo K, Vehige J. Puriteas a non-disruptive preservative for lubricating eye drop solutions in comparison to alternative preservatives [abstract].  Invest Ophthalmol Vis Sci.  2001;42(4):S39 ABS 223-B196.

24.              Demina NB, Chirkova MN, Astakhova AV, & Travina LA.  Contact lens maintenance systems.  Pharm Chem J. Feb 2001; 35(2):114-119.

25.              Adams J, Wilcox MJ, Trousdale MD, Chien D-S, Shimizu RW.  Morphologic and physiologic effects of artificial tear formulations on corneal epithelial derived cells. Cornea.  1992;11(3):234-41.

26.             Harding JJ.  Biochemistry of the eye.  London, Great Britain.  Chapman & Hall Medical, 1997:p. 6.

27.             Bachman WG, Wilson G.  Essential ions for maintenance of the corneal epithelial surface.  Invest Ophthalmol Vis Sci.  November 1985;26(11):1484-1488.

28.             Krezanoski JZ.  Chemical buffering of contact lens solutions.  Contact Lens Forum.  Dec 1988;13(12):60.

29.             Hom MM & Simmons PA.  Current multipurpose solution concepts.  Contact Lens Spectrum.  Sep 2001;16(9):33-34, 36, 38-39.

30.             Doughty MJ.  Re-wetting, comfort, lubricant and moisturising solutions for the contact lens wearer.  Contact Lens and Anterior Eye.  1999;22(4):116-126.

31.              Snibson GR, Greaves JL, Soper NDW, Tiffany JM, Wilson CG, Bron AJ.  Ocular surface residence times of artificial tear solutions. Cornea.  1992;11(4):288-293.

32.              Avisar R, Creter D, Levinsky H, Savir H. Comparative study of tear substitutes and their immediate effect on the precorneal tear film. Isr J Med Sci. Mar 1997;33(3):194-197.

33.              Farris RL.  The dry eye: its mechanisms and therapy, with evidence that contact lens is a cause. CLAO J.  Oct 1986;12(4):234-246.

34.              Glasson MJ, Stapleton F, Keay L, Sweeney D, Willcox MDP.  Differences in clinical parameters and tear film of tolerant and intolerant contact lens wearers.  Invest Ophthalmol Vis Sci.  Dec 2003;44(12):5116-5124.

35.             D’Arienzo P. Understanding and meeting the challenges of dry eye.  Rev Ophthalmol.  Aug 2002; 9(8):41, 44-45.